SNDL Inc.
NASDAQ:SNDLDrug Manufacturers - Specialty & Generic
-$0.03 today
- Market cap
- $326.64M
- Beta
- 0.91
- P/E (TTM)
- -47.4
- EPS (TTM)
- -$0.04
Volume 1.00M
Average 2.21M
SNDL EBITDA Margin
EBITDA as a percentage of revenue.
SNDL Inc.NASDAQ: SNDL
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to 1.4%
EBITDA Margin was 1.4% in Q1 FY2026, up 0.7 pp from a year earlier. On a trailing-twelve-month basis it was 5.3%, up 10.5 pp year over year. Over 3 fiscal years it widened by 50.9 pp.
Context
- EBITDA Margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 2 analysts of -1.5% for the fiscal year ending Dec 2026, down from 5.1% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 1.4%-8.7 pp QoQ
- Last fiscal yearDec 2025
- 5.1%+9.5 pp YoY
- LTMMar 2026
- 5.3%+10.5 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.7 pp | -1.3 pp | -2.1 pp |
| 1 year | +9.5 pp | -6.6 pp | -16.2 pp |
| 3 years | +50.9 pp | +1.7 pp | -49.2 pp |
| 5 years | +5.5 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 5.1%
- Year-over-year change
- +9.5pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.1% | +9.5pp |
| FY2024 | 2024-12-31 | -4.5% | +6.4pp |
| FY2023 | 2023-12-31 | -10.9% | +34.9pp |
| FY2022 | 2022-12-31 | -45.9% | +352.8pp |
| FY2021 | 2021-12-31 | -398.7% | — |
EBITDA Margin vs competitors
How SNDL compares with its peers on the latest reported figures
- SNDL's LTM Mar 2026 EBITDA Margin of 5.3% is the 5th highest of the 8 companies compared; the peer median is 7.3%.
- Its year-over-year change of +10.5 pp is the 2nd highest of 8, against a peer median of +6.2 pp.
- Over three fiscal years its change of +50.9 pp compares with a peer median of +8.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 29.3% | -22.9 pp | -7.6 pp | |
| LTM Mar 2026 | 22.8% | +10.3 pp | +31.0 pp | |
| LTM Mar 2026 | 9.5% | +43.6 pp | +249.5 pp | |
| LTM Mar 2026 | 7.3% | +8.1 pp | +4.2 pp | |
| LTM Mar 2026 | 5.3% | +10.5 pp | +50.9 pp | |
| LTM Mar 2026 | -2.5% | -5.1 pp | +8.2 pp | |
| LTM Mar 2026 | -4.6% | +6.2 pp | +28.7 pp | |
| LTM Mar 2026 | -102.7% | -35.0 pp | -65.4 pp | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding SNDL) | 7.3% | +6.2 pp | +8.2 pp | |
Competitors are the stored peer set for SNDL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 56.13M | 712.2M | 909.01M | 920.45M | 946.4M |
| Cost of Revenue | 65.13M | 571.82M | 718.59M | 680.12M | 687.75M |
| Gross Profit | (9M) | 140.38M | 190.42M | 240.33M | 258.65M |
| Gross Margin | -16.0% | 19.7% | 20.9% | 26.1% | 27.3% |
| Research & Development | 2.45M | 2.45M | 324K | 346K | 489K |
| Selling, General & Admin | 55.39M | 158.26M | 230.17M | 219.28M | 210.63M |
| Operating Expenses | 125.38M | 488.15M | 353.59M | 344.14M | 263.07M |
| Depreciation & Amortization | 10.16M | 47.32M | 64.95M | 56.71M | 56.27M |
| EBITDA | (223.76M) | (326.55M) | (99.15M) | (41.2M) | 48.02M |
| EBITDA Margin | -398.7% | -45.9% | -10.9% | -4.5% | 5.1% |
| Operating Income | (134.38M) | (347.77M) | (163.17M) | (103.81M) | (4.42M) |
| Operating Margin | -239.4% | -48.8% | -18.0% | -11.3% | -0.5% |
| Interest Income | 13.72M | 17.62M | 15.37M | 16.4M | 8.05M |
| Interest Expense | 776K | 5.9M | 7.92M | 7.7M | 7.52M |
| Other Income / Expenses | (100.32M) | (32M) | (8.85M) | (1.8M) | (11.35M) |
| Income Before Tax | (234.7M) | (379.77M) | (172.02M) | (105.61M) | (15.77M) |
| Pre-Tax Margin | -418.1% | -53.3% | -18.9% | -11.5% | -1.7% |
| Income Tax Expense | (7.91M) | (7.34M) | 0 | (9.41M) | 0 |
| Net Income | (226.98M) | (335.11M) | (172.66M) | (94.8M) | (15.77M) |
| Net Margin | -404.4% | -47.1% | -19.0% | -10.3% | -1.7% |
| EPS (Basic) | (1.24) | (1.50) | (0.65) | (0.38) | (0.06) |
| EPS (Diluted) | (1.24) | (1.50) | (0.65) | (0.38) | (0.06) |
| Weighted Avg Shares | 186.04M | 229.87M | 259.37M | 264.2M | 258.05M |
| Weighted Avg Shares (Diluted) | 186.04M | 229.87M | 259.37M | 264.2M | 258.05M |
SNDL Inc.
NASDAQ:SNDL
Intrinsic Alpha fair value
Locked
Current Price
$1.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.